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Introduction: SYNTAX score is a unique angiographic scoring system that provide
guidance as a predictive tool on the optimal technique of revascularization (CABG or
PCI) for patients with multivessel disease as well as left main disease. This scoring
system may help predict prognosis based on disease complexity in coronary vascu-
lature. In this study we aim to compare the CT-based SYNTAX score and the
conventional angiography-based SYNTAX score.
Materials-Methods: A sample of 107 consecutive coronary artery disease patients
(mean age 5612 years) who underwent CT coronary angiography were subsequently
studied by conventional coronary angiography. Post-CABG patients were excluded
from the study.
Results: The positive and negative predictive values of CT coronary angiography
were 97% and % 83 respectively when compared with conventional coronary angi-
ography. The studied population was divided into three groups according to their
SYNTAX score tertiles (Group 1 if <22; Group 2 if 23-32 and Group 3 if >33. There
was no signiﬁcant statistical difference between CT coronary angiography and
conventional angiography-derived SYNTAX Scores in all three groups (p<.05)
(Table 1).
Conclusion: Our trial study groups were similar with respect to CT coronary angi-
ography and conventional angiography-derived SYNTAX Scores. CT coronary
angiography derived syntax score can be used to predict coronary heart disease
prognosis.Table 1
KAG syntax BT syntax P
Group 1 37,1+4,6 37,1+4,1 NS
Group 2 26,9+3,2 26,6+3,2 NS
Group 3 11,1+6,5 11,5+7,0 NS
Table 1
Conventional angiography syntax CT syntax P
Group 1 37,1+4,6 37,1+4,1 NS
Group 2 26,9+3,2 26,6+3,2 NS
Group 3 11,1+6,5 11,5+7,0 NSCongestive Heart Failure
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Aim: We aimed to evaluate the importance of SYNTAX risc scoring system (SS) in
predicting the development of left ventricular systolic dysfunction (LVSD) and acute
ischemic heart failure (AIHF) after ST segment elevation myocardial infarction
(STEMI).C56 JACC VMethods: 640 patients admitted to our center with STEMI between December 2011-
October 2012 were evaluated. 428 of these; (261 anterior STEMI, 167 inferior
STEMI, 328 male, mean age; 63,713,7) who met the criteria were included in
the study. Patients were divided into three groups according to their ejection
fractions (EF). These groups were low EF group (LEFG, EF <%35), moderate EF
group (MEFG, EF %35-45) and preserved EF group (PEFG, EF >%45). In addition
to this, the patients devided into another three groups according to their SS values
(Low-SS <22, Moderate-SS¼22-33, High-SS >33). For diagnosis of the AIHF,
we considered to European Society of Cardiology heart failure guideline's
recommendations.
Findings: Heart rate, blood glucose, peak troponin-I, creatinine and SS values were
signiﬁcantly higher in the LEFG group. LAD was the infarct related artery in patients
with the LEFG and High-SS groups greatly. The number of the patients as AIHF,
morbidity and mortality rates were higher in the LEFG and High-SS groups. SS
means were signiﬁcantly higher in LEFG group (27.27.6) than MEFG (24.18.8)
and PEFG (18.98.1) groups (LEFG-MEFG; p¼0.005, LEFG-PEFG; p<0.001).
Furthermore, MEFG group's SS means were signiﬁcantly higher than PEFG
group (MEFG-PEFG; p<0.001) (Figure 1). There was a moderate level negative
correlation between EF and SS (r¼-0.401); and low level positive correlation
between SS and peak troponin-I levels (r¼0.162) (Figure 2). In the ROC analysis
for the prediction of the LEFG group, area under curve (AUC) value was 0.697
and cut of SS was 26.25 ((95% C.I.; 0.645-0.749), sensitivity; %57.5, speciﬁcity;
74%) (Figure 3).
Results: Syntax is a scoring system related to lesions complexity in acute coronary
syndromes and the severity of atherosclerosis. SS calculation is useful to evaluate the
development of AIHF after STEMI. A high SS can be used as a predictor of acute
ischemic heart failureol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
The relationship between PPI usage and development of major cardiovascular
events at in-hospital
PPI (+)
n¼232
PPI (-)
n¼71 p
Lansoprazole
n¼90
Pantoprazol
n¼115
Omeprazol
n¼20
Rabeprazol
n¼7 p
Angina
pectoris
14
%6
4
%5.6
1.000 4
%4.4
p¼0.474
6
%5.1
p¼0.023
4
%20
p¼0.023
0 0.169
Dyspnea 12
%5.2
1
%1.4
0.313 0 8
%6.9
4
%20
0 0.001
Heart
failure
18
%7.8
1
%1.4
0.054 0 12
%10.2
6
%30
0 <0.001
Arrhythmia 17
%7.3
3
%4.2
0.428 3
%3.3
11
%9.3
3
%15
0 0.177
Elevated
cardiac
markers
9
%3.9
5
%7.0
0.329 1
%1.1
5
%4.2
3
%15
0 0.062
ECG
changes
14
%6.0
4
%5.6
1.000 4
%4.4
6
%5.1
4
%20
0 0.169
ST
elevation
MI
1
%0.4
0 1.000 0 0 1
%5.0
0 0.066
Non-ST
elevation
MI
11
%4.7
4
%5.6
0.757 2
%2.2
6
%5.1
3
%15
0 0.931
Necessity
to CAG
20
%8.7
3
%4.2
0.218 4
%4.4
13
%11.1
3
%15
0 0.156
Necessity
to PCI
16
%6.9
4
%5.6
1.000 4
%4.4
10
%8.5
2
%10.0
0 0.688
GI
bleeding
1
%0.4
0 1.000 0 1
%1.0
0 0 1.000
Death 13
%5.6
1
%1.4
0.201 3
%3.3
7
%5.9
3
%15
0 0.145
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Introduction: Aspirin (ASA) and clopidogrel are still primary treatment options for
patients with acute coronary syndrome (ACS). The application of dual antiplatelet
therapy (DAPT) is also known to reduce major cardiovascular events for such patients.
However, DAPT has been shown to have serious gastrointestinal (GI) side effects and
to avoid these side effects the proton pump inhibitors (PPI) are added to the treatments
for many patients. There are conﬂicting reports in the literature whether the use of
PPI with clopidogrel increases major cardiovascular events or not. In this study, we
planned to investigate the effects of the use of PPI, in addition to DAPT, towards
developing major cardivascular events on the patients treated in the intensive care unit,
and whether these effects differ among PPIs.
Methods: 303 patients with ACS from the intensive care unit were included in this
study. While all of the patients were using ASA and clopidogrel, 232 of them were
using PPI. The patients using PPI were divided into 4 groups according to the types of
PPI which are lansoprazole, pantoprazole, omeprazole and rabeprazole. In-hospital
angina pectoris, shortness of breath, changes in ECG, cardiac enzyme elevation, heart
failure, arrhythmias, and reinfarct development, coronary angiography (CAG) and
percutaneous coronary intervention (PCI) requirement, the development of GI
bleeding and mortality were examined on these patients. The same data was evaluated
at ﬁrst and sixth months after discharge.
Findings: In our study no difference was observed between PPI users and non-users
in terms of in-hospital angina pectoris, dyspnea, arrhythmia, the development of heart
failure and ACS, need for CAG or PCI, development of GI bleeding and mortality.
When the PPI groups were evaluated among each other, the development of dyspnea
and heart failure was seen more in the patients using omeprazole. However, it was
realized that either these patients had initially been accepted with the shortness of
breath and heart failure complaints, or they had needed an intra-aortic balloon pump
and had been treated with omeprazole as the only intravenous PPI option available to
us at the time. At the end of the ﬁrst and sixth months there were no differences found
in terms of the development of cardiovascular events.
Conclusion: It is concluded that the PPI use does not have any negative impacts of
causing development of cardiovascular events in intensive care unit patients who are
diagnosed with acute coronary syndrome and who are receiving DAPT. Moreover, it
is seen that the combination of clopidogrel and PPI treatments are safe. In addition, no
differences were observed among the subgroups of PPI.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAInterventional Cardiology
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Aim: Contrast induced nephropathy is associated with permanent renal dysfunction
and increased mortality. Few data is available regarding its effect on event-free
survival of patients with non-ST elevation myocardial infarction (NSTEMI).
Methods: Patients with NSTEMI who underwent early coronary angiography were
analysed retrospectively. Exclusion criteria were previous exposure to contrast agents
within 7 days, hemodynamic instability or emergent procedures, and end stage renal
failure requiring chronic hemodialysis treatment. Contrast induced nephropathy (CIN)
was deﬁned as either 25% or 0.5 mg/dl increase in preprocedural serum creatinine
within 72 hours of the procedure. Follow-up data of patients were acquired from
hospital records. Patients without follow-up data were invited to hospital by phone
call. Clinical endpoints of the study were mortality and nonfatal myocardial infarction
(MI) in long term follow-up.
Results: 312 consecutive patients (mean age 5912 years, 76% male) with complete
serum creatinine measurements and long term clinical follow-up data (median
38 months) were included in the study. CIN developed in 9.6% (30) of patients.
Independent predictors of CIN were contrast volume/estimated glomerular ﬁltration
rate ratio [odds ratio 1.294 (1.062-1.577), p¼.011], left ventricular ejection fraction
[odds ratio 0.950 (0.911-0.990), p¼0.015] and hemoglobin concentration [odds ratio
0.755 (0.601-0.949), p¼0.016]. Death or nonfatal myocardial infarction was observed
more frequently in patients with CIN during the follow-up compared to patients
without (43.3% vs 19.9% respectively, chi-square¼10.4, log rank p¼0.005). Inde-
pendent predictors of long term mortality were left ventricular ejection fraction
[X2¼23,5, OR¼0.930 (0.903-0.958), p<0.001], age [X2¼4.3, OR¼1.028 (1.002-
1.056), p<0.038], and baseline creatinine [X2¼4.2, OR¼1.725 (1.021-2.913),
p¼0.042].
Conclusion: CIN after invasive procedures in patients with NSTEMI is associated
with increased mortality and cardiac events. Patients who developed CIN during acute
coronary syndromes should be considered as high-risk group and clinical follow-up
should be done accordingly. However CIN is not an independendent predictor of long
term mortality or recurrent events in patients with NSTEMI.LS C57
